These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 6685633
1. Standardization of steroid receptor assays in human breast cancer--II. Samples with low receptor content. Koenders A, Thorpe SM. Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1467-72. PubMed ID: 6685633 [Abstract] [Full Text] [Related]
2. Standardization of steroid receptor assays in human breast cancer--I. Reproducibility of estradiol and progesterone receptor assays. Koenders A, Thorpe SM. Eur J Cancer Clin Oncol; 1983 Sep; 19(9):1221-9. PubMed ID: 6684569 [Abstract] [Full Text] [Related]
3. Standardization of steroid receptor assays in human breast cancer--III. Selection of reference material for intra- and inter-laboratory quality control. Thorpe SM, Koenders A. Eur J Cancer Clin Oncol; 1986 Aug; 22(8):939-44. PubMed ID: 3770051 [Abstract] [Full Text] [Related]
4. Estrogen and progesterone receptor assays in human breast cancer: sources of variation between laboratories. Borjesson BW, McGinley R, Foo TM, Smyth C, Toppila M, Compton P, Sarfaty GA. Eur J Cancer Clin Oncol; 1987 Jul; 23(7):999-1004. PubMed ID: 3666003 [Abstract] [Full Text] [Related]
5. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols. Goussard J, Lechevrel C, Martin PM, Roussel G. Cancer Res; 1986 Aug; 46(8 Suppl):4282s-4287s. PubMed ID: 2425945 [Abstract] [Full Text] [Related]
6. Standardization of steroid receptor assays in human breast cancer--IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays. Koenders A, Thorpe SM. Eur J Cancer Clin Oncol; 1986 Aug; 22(8):945-52. PubMed ID: 3770052 [Abstract] [Full Text] [Related]
7. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Foekens JA, Portengen H, van Putten WL, Peters HA, Krijnen HL, Alexieva-Figusch J, Klijn JG. Cancer Res; 1989 Nov 01; 49(21):5823-8. PubMed ID: 2676151 [Abstract] [Full Text] [Related]
8. A quality control study to assess the inter-laboratory variability of routine estrogen and progesterone receptor assays. Zava DT, Wyler-von Ballmoos A, Goldhirsch A, Roos W, Takahashi A, Eppenberger U, Arrenbrecht S, Martz G, Losa G, Gomez F, Guelpa C. Eur J Cancer Clin Oncol; 1982 Aug 01; 18(8):713-21. PubMed ID: 6891322 [Abstract] [Full Text] [Related]
9. Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols. Ryan ED, Clark AF, Mobbs BG, Ooi TC, Sutherland DJ, Tustanoff ER. Clin Biochem; 1985 Feb 01; 18(1):20-6. PubMed ID: 3986988 [Abstract] [Full Text] [Related]
10. [Comparison of enzyme immunoassay and tritiated steroid binding assay for estrogen and progesterone receptor in 56 breast cancer cytosols]. Noguchi S, Miyauchi K, Nishizawa Y, Koyama H. Nihon Gan Chiryo Gakkai Shi; 1988 Jun 20; 23(6):1257-64. PubMed ID: 3068322 [No Abstract] [Full Text] [Related]
11. Quality control study of estradiol and progesterone receptor determination. Vermousek I, Számel I. Neoplasma; 1988 Jun 20; 35(3):307-14. PubMed ID: 3405339 [Abstract] [Full Text] [Related]
12. Impact of standardization of estrogen and progesterone receptor assays of breast cancer biopsies in Denmark. Thorpe SM, Poulsen HS, Pedersen KO, Rose C. Eur J Cancer Clin Oncol; 1988 Aug 20; 24(8):1263-9. PubMed ID: 3181248 [Abstract] [Full Text] [Related]
13. Quality control of estrogen receptor assays in The Netherlands. Koenders T, Benraad TJ. Breast Cancer Res Treat; 1983 Aug 20; 3(3):255-66. PubMed ID: 6367854 [Abstract] [Full Text] [Related]
14. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols. Noguchi S, Miyauchi K, Imaoka S, Koyama H, Iwanaga T. Eur J Cancer Clin Oncol; 1988 Nov 20; 24(11):1715-9. PubMed ID: 3061826 [Abstract] [Full Text] [Related]
15. Monoclonal antibodies for progesterone receptor assays and polymorphism studies in breast cancer. Comparison with radioligand assays. Goussard J, Magdelenat H, Martin PM, Lechevrel C, Roussel G. Bull Cancer; 1988 Nov 20; 75(8):771-82. PubMed ID: 3052654 [Abstract] [Full Text] [Related]
16. Intra- and inter-laboratory reproducibility of estrogen and progesterone receptor enzyme immunoassay in breast cancer cytosol samples--a Swedish multicenter study. Swedish Society of Cancer Study Group. Fernö M, Bendahl PO, Brisfors A, Byman K, Ekeberg M, Ferraud L, Grankvist K, Hjalmers B, Nilsson A, Sellberg G, Skoog L, Stål O, Wingmo I. Acta Oncol; 1997 Nov 20; 36(8):793-8. PubMed ID: 9482684 [Abstract] [Full Text] [Related]
17. Precision in estrogen and progesterone receptor assays. Results of the first CAP pilot survey. Oxley DK, Haven GT, Wittliff JL, Gilbo D. Am J Clin Pathol; 1982 Oct 20; 78(4 Suppl):587-96. PubMed ID: 7137099 [Abstract] [Full Text] [Related]
18. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC. Cancer Res; 1979 May 20; 39(5):1447-54. PubMed ID: 427788 [Abstract] [Full Text] [Related]
19. Improved measurement of androgen receptors in human breast cancer. Lea OA, Kvinnsland S, Thorsen T. Cancer Res; 1989 Dec 15; 49(24 Pt 1):7162-7. PubMed ID: 2582456 [Abstract] [Full Text] [Related]
20. Quality control program of steroid receptor assays: an international study. Vermousek I, Számel I, Goerlich M, Brdar B, Cvrtila D, Graf D, Padovan R, Paszko Z, Safarcík K. Neoplasma; 1992 Dec 15; 39(1):65-9. PubMed ID: 1382235 [Abstract] [Full Text] [Related] Page: [Next] [New Search]